Logo

Bulldog Bio to Distribute ChromoTek Products in US, Canada

Oct 25, 2013 | staff reporter

NEW YORK (GenomeWeb News) – ChromoTek today announced it has signed a contract with Bulldog Bio to distribute ChromoTek's entire line of affinity reagents in the US and Canada.

Portsmouth, NH-based Bulldog will sell and support ChromoTek's line of novel tools for protein and cell biology. Financial and other terms were not disclosed.

ChromoTek is based in Planegg-Martinsried, Germany and offers immunologic research tools derived from single domain alpaca antibodies for cell biology and proteomics. The company is a spinout of the Ludwig-Maximilians University Munich.

Filed under

Proteomics & Protein Research
Business News
distribution agreement
proteomics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.